Case finding, cascade screening and treatment for familial hypercholesterolemia (NHLBI)

• Date: 07 May 2020
• Published date: 07 May 2020
• DOI: http://doi.org/10.1002/fgc.31066

Page 8 Federal Grants & Contracts ■ May 7, 2020

© 2020 Wiley Periodicals, Inc., A Wiley Company All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

PAYMENT OPTIONS:

(all payments must be in U.S. dollars)

❏My Check payable to John Wiley & Sons is enclosed.

To make payment by credit card, please contact Customer Service 24 × 7 at

+1-800-835-6770.

Name: Title:

Company:

Address:

City: State: ZIP Code:

Email: Phone:

❑ Yes, I’d like to hear about special discount offers, new products, and more.

Place me on the Jossey-Bass email list.

Individual rate subscriptions must be paid by personal check or credit card. All orders subject to credit

approval. Price includes postage, packing, and handling charges worldwide. Canadian residents

add GST and any local sales tax. GST #128424017. Individual-rate subscriptions may not be

resold or used as library copies.

4 EASY WAYS TO ORDER

CALL Toll-Free: 800.835.6770

MAIL:

John Wiley & Sons Inc.

P.O. Box 55381

Boston, MA 02205-9850

EMAIL: cs-journals@wiley.com

ONLINE AT: wileyonlinelibrary.com/journal/fgc

Jossey-Bass/Wiley Guarantee: If you are not completely

satisfied with this newsletter, let us know and we will refund

the cost of your subscription.

❑ YES! Please start my one-year subscription (24 issues) to

Federal Grants and Contracts for $446

Case nding, cascade screening and treatment

for familial hypercholesterolemia (NHLBI)

Scope: The National Heart, Lung, and Blood Institute

seeks (R61/R33) exploratory/developmental phased

award applications for the Implementation Research

to Improve Case Finding, Cascade Screening, and

Treatment for Familial Hypercholesterolemia (FH)

announcement or single-site clinical trials.

Deadline: Letters of Intent, Feb. 8, 2021; proposals,

March 8, 2021.

Funds: Up to $2 million in total costs for new awards.

The maximum combined project period is ve years.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: NHLBI said examples include but are not

limited to those that: develop and test generalizable,

cost-effective and sustainable strategies at the local,

state or national levels for nding FH and connecting

patients to clinical sources of care; develop and test

strategies that leverage data science approaches

using electronic health records, clinical decision tools,

machine learning and clinical algorithms to test models

for nding FH index patients, cascade screening and

optimizing treatment strategies across rural and urban

areas; develop and test the feasibility, cost-effectiveness

and scalability of case detection and cascade screening

strategies across diverse clinical settings; and develop

and test optimal and sustainable strategies to promote

the adoption and sustainability of diagnosis and

cascade screening for FH within underrepresented

populations, rural communities and low-resource

settings.

➜ www.grants.gov; FON# RFA-HL-22-006

Lasker Clinical Research Scholars Program (NIH)

Scope: The National Institutes of Health seeks

applications for the Lasker Clinical Research Scholars

Program announcement for the purpose of supporting

the research activities during the early-stage careers of

independent clinical researchers.

Deadline: Aug. 28, 2020.

Funds: To be determined. The maximum project period

is up to ve years.

Eligibility: Colleges and universities; for-prot

organizations, including small businesses; nonprot

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: Research areas of interest vary by institute and

center. The rst phase will support scholars for up to

ve years, with the possibility of an extension for an

additional two years. Upon successfully completing

the initial Intramural Research Program (IRP) phase

of the program, the Lasker Scholar will be eligible for

two options in the second phase: (1) remaining in the

IRP with continued intramural funding and progression

to tenured senior investigator status, if consistent

with formal reviews and assessments; or (2) being

considered for up to three years of support to continue

their research as independent clinician scientists at an

extramural institution.

➜ www.grants.gov; FON# PAR-20-167 ■